首页> 美国卫生研究院文献>Journal of Radiation Research >Organ-specific modulation complexity score for the evaluation of dose delivery
【2h】

Organ-specific modulation complexity score for the evaluation of dose delivery

机译:器官特异性调制复杂度评分用于评估剂量输送

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The purpose of this study was to correlate the modulation complexity score (MCS) with organ location and to predict potential dose errors for organs before beam delivery for intensity-modulated radiation therapy (IMRT) dosimetry. Sixteen head and neck cancer patients treated with IMRT were selected. Distribution of the relative dose error on each beam was performed using forward projection to the planned dose to compute the predicted dose after doing per-beam quality assurance. Original organ-specific modulation complexity score (oMCS) was created based on a modified MLC, which depended on organ location. First, MCS was calculated based on the change in leaf position between adjacent MLC leaves. Second, the segment edge map (SEM) calculated from the intensity map for each beam was applied to the calculation volume. The oMCS with segment edge (oMCSedge) was derived from the product of oMCS and SEM. The correlation between the dose errors (planned and predicted) and oMCSedge values was evaluated for the target and organs at risk. We have also expanded the original MCS concept to oMCSedge including the organ location. We observed a moderate correlation between the dose errors and oMCSedge for all organs and volumes of interest except the gross tumor volume, brain stem, and spinal cord. In other organs, a moderate improvement in sensitivity was observed on the SEM, which was correlated with dose errors. Although the implementation of oMCSedge would be impractical for normal clinical settings, it is expected that oMCSedge would help a treatment planner to judge whether or not the treatment plan would be acceptably delivered.
机译:这项研究的目的是将调制复杂度评分(MCS)与器官位置相关联,并预测在进行强度调制放射治疗(IMRT)剂量测定的光束传输之前器官的潜在剂量误差。选择了十六名接受IMRT治疗的头颈癌患者。使用前向投影到计划剂量进行每个光束上相对剂量误差的分布,以在进行每束质量保证后计算预测剂量。原始器官特定的调制复杂度评分(oMCS)基于修改后的MLC(取决于器官位置)创建。首先,根据相邻MLC叶片之间叶片位置的变化计算MCS。其次,将从强度图针对每个光束计算的分段边缘图(SEM)应用于计算量。具有段边缘的oMCS(oMCSedge)源自oMCS和SEM的乘积。针对目标和处于风险中的器官,评估了剂量误差(计划的和预测的)与oMCSedge值之间的相关性。我们还将原始的MCS概念扩展到包括器官位置在内的oMCSedge。我们观察到除总肿瘤体积,脑干和脊髓外,所有器官和目标体积的剂量误差与oMCSedge之间存在中等相关性。在其他器官中,在SEM上观察到灵敏度的适度提高,这与剂量误差相关。尽管对于正常的临床环境而言,oMCSedge的实施是不切实际的,但是可以预期,oMCSedge可以帮助治疗计划者判断是否可以接受治疗计划。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号